Astragaloside A is a novel regulator of HIF-1?? and angiogenesis through the PI3K/Akt pathway in HUVECs that are exposed to hypoxia.
More Information Supplier PageAstragaloside A is a novel regulator of HIF-1?? and angiogenesis through the PI3K/Akt pathway in HUVECs that are exposed to hypoxia.
More Information Supplier PageAstragaloside A is a novel regulator of HIF-1?? and angiogenesis through the PI3K/Akt pathway in HUVECs that are exposed to hypoxia.
More Information Supplier PageChondroitin sulfate is a sulfated glycosaminoglycan (GAG) composed of a chain of alternating sugars.
More Information Supplier PageChondroitin sulfate is a sulfated glycosaminoglycan (GAG) composed of a chain of alternating sugars.
More Information Supplier PageMK-8245 is a Liver-Targeted Stearoyl-CoA Desaturase (SCD) Inhibitor. MK-8245 is useful for the Treatment of Diabetes and Dyslipidemia.
More Information Supplier PageMK-8245 is a Liver-Targeted Stearoyl-CoA Desaturase (SCD) Inhibitor. MK-8245 is useful for the Treatment of Diabetes and Dyslipidemia.
More Information Supplier PageMK-8245 is a Liver-Targeted Stearoyl-CoA Desaturase (SCD) Inhibitor. MK-8245 is useful for the Treatment of Diabetes and Dyslipidemia.
More Information Supplier PageAstragaloside A is a novel regulator of HIF-1?? and angiogenesis through the PI3K/Akt pathway in HUVECs that are exposed to hypoxia.
More Information Supplier PageLY2608204 is a potent used to treat type 2 diabetes. In a clinical trial, a study was performed to evaluate the safety and tolerability of LY2608204 in patients with type 2 diabetes.
More Information Supplier Page
